Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea · Delayed Price · Currency is KRW
71,800
-1,100 (-1.51%)
Feb 27, 2026, 3:30 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|
| Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 |
|---|
| 233.57B | 173.51B | 146.88B | 135.86B | 104.81B | | | | | |
| 34.61% | 18.13% | 8.11% | 29.62% | 40.25% | | | | | |
| 233.57B | 173.51B | 146.88B | 135.86B | 104.81B | | | | | |
| 34.61% | 18.13% | 8.11% | 29.62% | 40.25% | | | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|
| Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 |
|---|
| 231.98B | 172.30B | 145.91B | 133.72B | 101.81B | | | | | |
| 34.64% | 18.08% | 9.12% | 31.34% | 40.03% | | | | | |
| 138.91M | 61.78M | 35.35M | 393.12M | 864.55M | | | | | |
| 124.85% | 74.75% | -91.01% | -54.53% | - | | | | | |
| 566.66M | 343.49M | 390.40M | 414.15M | 359.33M | | | | | |
| 64.97% | -12.02% | -5.73% | 15.26% | -24.99% | | | | | |
| - | - | - | 16.73M | 31.79M | | | | | |
| - | - | - | -47.37% | - | | | | | |
Republic of The Philippines | 595.89M | 673.54M | 364.16M | 1.05B | 1.32B | | | | | |
Republic of The Philippines Growth | -11.53% | 84.96% | -65.23% | -20.80% | 48.09% | | | | | |
| 284.99M | 135.58M | 176.83M | 273.20M | 423.85M | | | | | |
| 110.20% | -23.33% | -35.27% | -35.54% | -35.25% | | | | | |
| 233.57B | 173.51B | 146.88B | 135.86B | 104.81B | | | | | |
| 34.61% | 18.13% | 8.11% | 29.62% | 40.25% | | | | | |
Source: S&P Global Market Intelligence.